Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Details for Australian Patent Application No. 2009206368 (hide)

Owner High Point Pharmaceuticals, LLC

Inventors Guzel, Mustafa; Mjalli, Adnan M M; Polisetti, Dharma Rao; Gaddam, Bapu; Kostura, Matthew

Agent Shelston IP

Pub. Number AU-A-2009206368

PCT Pub. Number WO2009/094528

Priority 61/023,617 25.01.08 US

Filing date 23 January 2009

Wipo publication date 30 July 2009

International Classifications

A01N 43/54 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/505 (2006.01) - Pyrimidines

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/094528 Priority application(s): WO2009/094528

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206370-Extrusion bonded laminates for absorbent articles

2009206365-Power headroom management in wireless communication systems